Green Leaf Pharmaceutical (02186.HK) announcement, on July 27th, 2022, the company entered into a subscription agreement with the subscriber (Xinye Biopharmaceutical Holdings Co., Ltd.). According to the subscription agreement, the subscriber agrees to subscribe for corporate bonds with a principal amount of RMB 1.2 billion equivalent to Hong Kong dollars.

All the prerequisites for the issue of corporate bonds set out in the subscription Agreement have been met. On August 16, 2022, the company issued corporate bonds with a total principal of 1.2 billion Hong Kong dollars to subscribers at the agreed exchange rate.